OCGN FY 2019 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$710M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$8M

Operating Income

-$14M

Net Income

-$20M

EPS (Diluted)

$-1.53

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$884,089

Balance Sheet

Total Assets

$17M

Total Liabilities

$6M

Stockholders' Equity

$11M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$8M	-$49,623	-16194.9%
Operating Income	-$14M	-$30M	+53.0%
Net Income	-$20M	-$9M	-134.2%